T. Creagh

Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.

R. Chaisson, D. Richman, J. Keruly, 1992, The American review of respiratory disease.

The metabolic fate of the methylnitroimidazole moiety of azathioprine in the rat.

P. de Miranda, L. M. Beacham, G. Elion, 1973, The Journal of pharmacology and experimental therapeutics.

The Use of Cohort Studies in Pharmacoepidemiology

T. Creagh, 1992 .

Safety and Pharmacokinetic Profile of Multiple Escalating Doses of (+)-Calanolide A, a Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy HIV-Negative Volunteers

M. Flavin, Ze-Qi Xu, J. Ruckle, 2002, HIV clinical trials.

Safety and Pharmacokinetics of Single Doses of (+)-Calanolide A, a Novel, Naturally Occurring Nonnucleoside Reverse Transcriptase Inhibitor, in Healthy, Human Immunodeficiency Virus-Negative Human Subjects

M. Flavin, Ze-Qi Xu, J. Ruckle, 2001, Antimicrobial Agents and Chemotherapy.

Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 human immunodeficiency virus-infected patients: findings of the Anemia Prevalence Study*

D. Mildvan, G. Leitz, T. Creagh, 2007, Current medical research and opinion.

Human immunodeficiency virus type 1 RNA level and CD4 count as prognostic markers and surrogate end points: A meta-analysis

S. Hammer, D. Katzenstein, R. Schooley, 2000 .

The metabolic disposition of 14C-azathioprine in the dog.

L. M. Beacham, G. Elion, T. Creagh, 1975, Journal of Pharmacology and Experimental Therapeutics.

Survival and disease progression according to gender of patients with HIV infection. The Terry Beirn Community Programs for Clinical Research on AIDS.

T. Louis, N. Kimmel, W. El-Sadr, 1994, JAMA.